調查批次:CHT2015-01 | 檢體寄出日期:2015-02-02 | 報告回收截止日期:2015-02-09 | 回收份數:21 |
TSH 檢驗院際品管調查結果: | ||
2.歷次品管檢體 TSH 檢驗值之實驗室間 CV 分佈圖 | ||
4.至本次各單位 z score 分佈圖 | 5.至本次各單位 D% 分佈圖 | 6.至本次各單位 SDI 分佈圖 |
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01b | RH01 | 2 |
1 |
3 |
7.6 |
-1.4 |
-15.6 |
-1.9 |
-0.2 |
-65 |
3.5 |
0.1 |
2.9 |
0.4 |
-0.8 |
12 |
RH07b | RH07 | 4 |
1 |
3 |
7.6 |
-1.4 |
-15.6 |
-1.9 |
-0.2 |
-65 |
3.7 |
0.3 |
8.8 |
1.1 |
0.8 |
37 |
RH14 | RH14 | 7 |
1 |
3 |
7.1 |
-1.9 |
-21.1 |
-2.6 |
-1.5 |
-88 |
3.5 |
0.1 |
2.9 |
0.4 |
-0.8 |
12 |
RH15 | RH15 | 7 |
1 |
3 |
7.6 |
-1.4 |
-15.6 |
-1.9 |
-0.2 |
-65 |
3.6 |
0.2 |
5.9 |
0.7 |
0.0 |
25 |
CL009 | CL009 | 3 |
1 |
3 |
7.3 |
-1.7 |
-18.9 |
-2.4 |
-1.0 |
-79 |
3.6 |
0.2 |
5.9 |
0.7 |
0.0 |
25 |
CL010 | CL010 | 3 |
1 |
3 |
8.1 |
-0.9 |
-10.0 |
-1.3 |
1.0 |
-42 |
3.4 |
0.0 |
0.0 |
0.0 |
-1.5 |
0 |
CL012 | CL012 | 7 |
1 |
3 |
7.7 |
-1.3 |
-14.4 |
-1.8 |
0.0 |
-60 |
3.6 |
0.2 |
5.9 |
0.7 |
0.0 |
25 |
CL013 | CL013 | 3 |
1 |
5 |
11.5 |
2.5 |
27.8 |
3.5 |
9.3 |
116 |
3.7 |
0.3 |
8.8 |
1.1 |
0.8 |
37 |
CL014a | CL014 | 7 |
1 |
3 |
7.7 |
-1.3 |
-14.4 |
-1.8 |
0.0 |
-60 |
3.5 |
0.1 |
2.9 |
0.4 |
-0.8 |
12 |
CL015 | CL015 | 7 |
1 |
3 |
8.0 |
-1.0 |
-11.1 |
-1.4 |
0.7 |
-46 |
3.8 |
0.4 |
11.8 |
1.5 |
1.5 |
49 |
Median of RIA Group |
7.7 |
3.6 |
||||||||||||||
Range of RIA Group |
7.1 - 11.5 |
3.4 - 3.8 |
||||||||||||||
Robust mean of RIA Group |
7.7 ( n = 10 ) |
3.6 ( n = 10 ) |
||||||||||||||
Robust SD of RIA Group |
0.41 |
0.13 |
||||||||||||||
CV of RIA Group |
5.3% |
3.6% |
||||||||||||||
Median of European RIA Labs |
9.8 ( n = 101 ) |
3.5 ( n = 103 ) |
||||||||||||||
Range of European RIA Labs ( 16% - 84% ) |
9.3 - 10.3 |
3.0 - 4.0 |
||||||||||||||
檢驗單位 <代碼> |
確診醫院 <代碼> |
回報 天數 |
檢體 S1 |
檢體 S2 |
||||||||||||
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
( mIU/L ) |
D |
D% |
z |
SDI |
Da% |
|||||
RH01a | RH01 | 7 |
3 |
9 |
9.4 |
0.4 |
4.4 |
0.6 |
0.1 |
19 |
3.1 |
-0.3 |
-8.8 |
-1.1 |
-0.6 |
-37 |
RH02c | RH02 | 7 |
3 |
1 |
10.6 |
1.6 |
17.8 |
2.2 |
1.3 |
74 |
3.1 |
-0.3 |
-8.8 |
-1.1 |
-0.6 |
-37 |
RH06 | RH06 | 3 |
3 |
9 |
9.1 |
0.1 |
1.1 |
0.1 |
-0.2 |
5 |
3.3 |
-0.1 |
-2.9 |
-0.4 |
0.0 |
-12 |
RH07a | RH07 | 2 |
3 |
2 |
8.3 |
-0.7 |
-7.8 |
-1.0 |
-1.0 |
-32 |
3.3 |
-0.1 |
-2.9 |
-0.4 |
0.0 |
-12 |
RH12 | RH12 | 4 |
3 |
2 |
8.9 |
-0.1 |
-1.1 |
-0.1 |
-0.4 |
-5 |
3.7 |
0.3 |
8.8 |
1.1 |
1.1 |
37 |
RH19 | RH19 | 2 |
3 |
2 |
10.9 |
1.9 |
21.1 |
2.6 |
1.6 |
88 |
4.0 |
0.6 |
17.6 |
2.2 |
2.0 |
74 |
RH20 | RH20 | 2 |
3 |
7 |
8.7 |
-0.3 |
-3.3 |
-0.4 |
-0.6 |
-14 |
2.8 |
-0.6 |
-17.6 |
-2.2 |
-1.4 |
-74 |
CL005 | CL005 | 7 |
3 |
9 |
8.7 |
-0.3 |
-3.3 |
-0.4 |
-0.6 |
-14 |
3.2 |
-0.2 |
-5.9 |
-0.7 |
-0.3 |
-25 |
CL006a | CL006 | 4 |
3 |
7 |
8.4 |
-0.6 |
-6.7 |
-0.8 |
-0.9 |
-28 |
2.9 |
-0.5 |
-14.7 |
-1.9 |
-1.1 |
-62 |
CL008 | CL008 | 4 |
3 |
2 |
10.2 |
1.2 |
13.3 |
1.7 |
0.9 |
56 |
3.1 |
-0.3 |
-8.8 |
-1.1 |
-0.6 |
-37 |
CL011 | CL011 | 3 |
3 |
13 |
9.0 |
0.0 |
0.0 |
0.0 |
-0.3 |
0 |
3.5 |
0.1 |
2.9 |
0.4 |
0.6 |
12 |
Median of CLIA Group |
9.0 |
3.2 |
||||||||||||||
Range of CLIA Group |
8.3 - 10.9 |
2.8 - 4.0 |
||||||||||||||
Robust mean of CLIA Group |
9.3 ( n = 11 ) |
3.3 ( n = 11 ) |
||||||||||||||
Robust SD of CLIA Group |
0.98 |
0.35 |
||||||||||||||
CV of CLIA Group |
10.5% |
10.6% |
||||||||||||||
Median of European CLIA Labs |
9.0 ( n = 1200 ) |
3.4 ( n = 1183 ) |
||||||||||||||
Range of European CLIA Labs ( 16% - 84% ) |
8.5 - 10.3 |
3.1 - 3.6 |
||||||||||||||
Median of All Labs |
8.4 |
3.5 |
||||||||||||||
Range of All Labs |
7.1 - 11.5 |
2.8 - 4.0 |
||||||||||||||
Robust mean of All Labs |
8.6 ( n = 21 ) |
3.4 ( n = 21 ) |
||||||||||||||
Robust SD of All Labs |
1.22 |
0.32 |
||||||||||||||
CV of All Labs |
14.2% |
9.4%
|
||||||||||||||
Median of All European Labs ( Xa ) |
9.0 |
3.4 |
||||||||||||||
Range of All European Labs ( 16% - 84% ) |
8.3 - 10.3 |
3.0 - 3.7 |
||||||||||||||
Mean of All European Labs |
9.2 ( n = 1412 ) |
3.4 ( n = 1403 ) |
||||||||||||||
SD of All European Labs |
1.23 |
0.40 |
||||||||||||||
CV of All European Labs |
13.4% |
11.9% |
||||||||||||||
SD for proficiency
assessment ( σp ) |
0.72 |
0.27 |
||||||||||||||
|
Method Code
|
Laboratory |
|
Radioimmunoassay ( Sandwich-type ) |
1 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL013, CL014a, CL015, |
Chemiluminescent Immunoassay ( Sandwich-type ) |
3 |
RH01a, RH02c, RH06, RH07a, RH12, RH19, RH20, CL005, CL006a, CL008, CL011, |
Reagent Code |
Laboratory |
|
Abbott Architect |
1 |
RH02c, |
Beckman Coulter Access |
2 |
RH07a, RH12, RH19, CL008, |
Cisbio RIA-gnost |
3 |
RH01b, RH07b, RH14, RH15, CL009, CL010, CL012, CL014a, CL015, |
Immunotech |
5 |
CL013, |
Siemens ADVIA Centaur |
7 |
RH20, CL006a, |
Siemens Immulite 2000 |
9 |
RH01a, RH06, CL005, |
Roche |
13 |
CL011, |
若有任何疑問,歡迎來電(函)聯繫或指教
財團法人預防醫學基金會
地 址:10699 台北郵政 26-624 號信箱 電 話:(02)
2703-6080
e-mail:
傳 真: (02)
2703-6070
updated
: 2015-02-10